Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Squibb

since

auto-detected in 4 stories

4 months ago

Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash.

10 months ago

Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.

page 1 of 1